Sfoglia per Autore
DESCRIZIONE DI UN CASO DI SEVERA INSULINO-RESISTENZA E LIPODISTROFIA PARZIALE, CAUSATO DA UNA MUTAZIONE A CARICO DEL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA (PPAR-GAMMA): CARATTERIZZAZIONE CLINICA E MOLECOLARE.
2013 I. Campi
The IGSF1 deficiency syndrome: characteristics of male and female patients
2013 S.D. Joustra, N. Schoenmakers, L. Persani, I. Campi, M. Bonomi, G. Radetti, P. Beck-Peccoz, H. Zhu, T.M.E. Davis, Y. Sun, E.P. Corssmit, N.M. Appelman Dijkstra, C.A. Heinen, A.M. Pereira, A.J. Varewijck, J.A.M.J.L. Janssen, E. Endert, R.C. Hennekam, M.P. Lombardi, M.M.A.M. Mannens, B. Bak, D.J. Bernard, M.H. Breuning, K. Chatterjee, M.T. Dattani, W. Oostdijk, N.R. Biermasz, J.M. Wit, A.S.P. van Trotsenburg
A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia
2014 N. Schoenmakers, C. Moran, I. Campi, M. Agostini, O. Bacon, O. Rajanayagam, J. Schwabe, S. Bradbury, T. Barrett, F. Geoghegan, M. Druce, P. Beck-Peccoz, A. O'Toole, P. Clark, M. Bignell, G. Lyons, D. Halsall, M. Gurnell, K. Chatterjee
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy
2014 N. Curro, D. Covelli, G. Vannucchi, I. Campi, G. Pirola, S. Simonetta, D. Dazzi, C. Guastella, L. Pignataro, P. Beck-Peccoz, R. Ratiglia, M. Salvi
Thyrotropin-secreting pituitary adenomas : outcome of pituitary surgery and irradiation
2014 E. Malchiodi, E. Profka, E. Ferrante, E. Sala, E. Verrua, I. Campi, A.G. Lania, M. Arosio, M. Locatelli, P. Mortini, M. Losa, E. Motti, P.L.M. Beck Peccoz, A. Spada, G. Mantovani
Syndromes of resistance to thyroid hormone action
2015 L. Persani, I. Campi, F. Marelli
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe graves' orbitopathy : a randomized controlled study
2015 M. Salvi, G. Vannucchi, N. Currò, I. Campi, D. Covelli, D. Dazzi, S. Simonetta, C. Guastella, L. Pignataro, S. Avignone, P. Beck-Peccoz
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy
2015 D. Covelli, G. Vannucchi, I. Campi, N. Currò, R. D'Ambrosio, M. Maggioni, U. Gianelli, P. Beck-Peccoz, M. Salvi
Fetal cell microchimerism : a protective role in autoimmune thyroid diseases
2015 V. Cirello, R. Rizzo, M. Crippa, I. Campi, D. Bortolotti, S. Bolzani, C. Colombo, G. Vannucchi, M.A. Maffini, F. de Liso, S. Ferrero, P. Finelli, L. Fugazzola
B cell activating factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases
2015 I. Campi, D. Tosi, S. Rossi, G. Vannucchi, D. Covelli, F. Colombo, E. Trombetta, L. Porretti, L. Vicentini, G. Cantoni, N. Currò, P. Beck-Peccoz, G. Bulfamante, M. Salvi
Therapy of endocrine disease : Endocrine dilemma : management of Graves' orbitopathy
2016 I. Campi, G. Vannucchi, M. Salvi
Retinal photoreceptor functions are compromised in patients with resistance to thyroid hormone syndrome (RTHβ)
2017 I. Campi, G. Cammarata, S. Bianchi Marzoli, P. Beck-Peccoz, D. Santarsiero, D. Dazzi, A. Bottari de Castello, E.G. Taroni, F. Viola, C. Mian, S. Watuntantrige Fernando, C. Pelusi, M. Muzza, M.A. Maffini, L. Persani
Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis
2018 D. Meringolo, I. Campi, G. Costante
Syndromes of Resistance to Thyroid Hormone Action
2019 L. Persani, I. Campi
Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis
2019 I. Campi, G. Perego, A. Ravogli, A. Groppelli, G. Parati, L. Persani, L. Fugazzola
Prevention of orbitopathy by oral or intravenous steroid prophylaxis in short duration Graves’ disease patients undergoing radioiodine ablation : A prospective randomized control trial study
2019 G. Vannucchi, D. Covelli, I. Campi, N. Curro, D. Dazzi, M. Rodari, G. Pepe, A. Chiti, C. Guastella, E. Lazzaroni, M. Salvi
Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy.
2020 G. Lanzolla, G. Vannucchi, I. Ionni, I. Campi, F. Sileo, E. Lazzaroni, M. Marinò
The Differential Diagnosis of Discrepant Thyroid Function Tests: Insistent Pitfalls and Updated Flow-Chart Based on a Long-Standing Experience
2020 I. Campi, D. Covelli, C. Moran, L. Fugazzola, C. Cacciatore, F. Orlandi, G. Gallone, K. Chatterjee, P. Beck-Peccoz, L. Persani
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy
2021 G.M. Vannucchi, I. Campi, D. Covelli, N. Curro, E. Lazzaroni, A. Palomba, D. Soranna, A. Zambon, L. Fugazzola, I. Muller, C. Guastella, M. Salvi
Quantification of global ocular motility impairment in graves' orbitopathy by measuring eye muscle ductions
2021 I. Campi, N. Currò, G. Vannucchi, D. Covelli, S. Simonetta, L. Fugazzola, L. Pignataro, D. Dazzi, C. Guastella, E. Lazzaroni, G. Pirola, M. Salvi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile